在持续的上皮缺陷中,局部胰岛素和自身血清之间的治疗疗效的比较:西班牙的一项随机对照试验协议
Pedro Arriola-Villalobos1, Barbara Burgos-Blasco2, Ana Ascaso-Del-Rio3
1Hospital Clinico San Carlos, Madrid, Spain.
BMJ open
|September 18, 2025
概括
这项研究调查了胰岛素眼滴是否有效治疗持续性上皮质缺陷 (PED),并将其与自身血清进行比较. 结果将指导用于挑战角膜愈合的新疗法.
科学领域:
- 眼科医生 眼科 眼科
- 角膜疾病研究 角膜疾病研究
- 临床试验 临床试验
背景情况:
- 长期上皮缺陷 (PED) 是一个重大的临床挑战.
- 目前的治疗方法包括滑,带隐形眼镜,点塞塞,和自身血清 (AS).
- 局部胰岛素显示有望增强角膜上皮的愈合.
研究的目的:
- 评估局部胰岛素眼滴在治疗PED时的疗效和安全性.
- 为了将胰岛素眼滴与自身血清 (AS) 进行比较,作为二线治疗.
- 进行一个多中心,随机,盲目的临床试验.
主要方法:
- 标准治疗后长期表皮缺陷的患者将被纳入.
- 参与者将被随机分配,接受胰岛素 (1 IU/mL) 或AS (20%) 眼滴3个月.
- 通过完全上皮质化,上皮质化速率和盲目观察员评估的关闭时间来评估有效性.
主要成果:
- 这项研究旨在确定胰岛素眼滴是否会导致持续的上皮缺陷更快或更完整地愈合.
- 将评估胰岛素眼滴的安全性和耐受性.
- 胰岛素和AS治疗组之间的表皮质化率的比较.
结论:
- 该研究预计将提供关于胰岛素眼滴在PED管理中的有效性的证据.
- 这些发现可能会将胰岛素作为一种可行的替代品或现有治疗方法的辅助.
- 结果将为耐火角膜上皮缺陷的临床实践指南提供信息.
更多相关视频
10:43Oligomerization Dynamics of Cell Surface Receptors in Living Cells by Total Internal Reflection Fluorescence Microscopy Combined with Number and Brightness Analysis
Published on: November 6, 2019
7.2K
04:04Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness
Published on: July 11, 2025
1.4K
相关概念视频
Clinical Applications of Epidermal Stem Cells
2.4K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.4K
Insulin: Dosing Regimen and Adverse Effects
1.3K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K
